Home › Small Cell Lung Cancer › Maryland
Small Cell Lung Cancer clinical trials in Maryland
19 studies for Small Cell Lung Cancer are looking for participants at sites in Maryland.
Cities in Maryland
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02146170Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT07509034DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- University of Maryland School of Medicine, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07472517Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- United Theranostics, Glen Burnie
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07278479A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Sep 22, 2026 · NCT06066138A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- American Oncology Partners, PA - The Center for Cancer and Blood Disorders, Bethesda
- Maryland Oncology Hematology, Silver Spring
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07218146Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06712355Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- University of Maryland, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07057791A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06095505Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated Aug 13, 2026 · NCT06228066A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
- John Hopkins School of Medicine, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06203210DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- University of Maryland School of Medicine, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05882058A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06131840A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05652686Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Johns Hopkins University, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT0525755118F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated May 19, 2026 · NCT06503146Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- University of Maryland/Greenebaum Cancer Center, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06769126Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT05450965From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.